| Click here to view the March Issue |
|
![]() |
|
| Click here to view The 2009 Pharma Choice Awards |
![]() |
| Anna Stashower President/Publisher Welcome to PM360 |
|
COMMON SENSE By Bud Bilanich |
![]() |
| We All Need Friends |
![]() |
| HOT TOPICS | |
![]() |
Drug Collaborations on the Rise Experts say drug collaborations are on the rise as pharmaceutical companies pool resources in an effort to share the cost and risk of drug development. |
| Are Free Samples a Health Hazard? New research shows that free drug samples distributed in pediatric clinics may be unsafe, according to a study published in Pediatrics. |
|
| Potential FDA Restrictions on Medical Device DTC Ads Chairman of the Senate Aging Committee Herb Kohl (D-WI) is investigating issues dealing with direct-to-consumer (DTC) advertising of medical devices. |
|
| Publicly Reporting Fees to Physicians Eli Lilly & Company and Merck & Company announced that starting in 2009, they will begin publicly reporting their payments made to outside doctors. |
| FEATURES | |
![]() |
Rethinking the Tried and True: The New Brand Marketing Tactics By Alan Topin No effective strategy—whether it’s used for war or personal relationships or product marketing is guaranteed to work forever. Thus, brand managers and marketing agencies must create new and adapt traditional marketing tactics to best engage and reach their target audiences. |
![]() |
Has DTC Spending Reached a High Water Mark? By John Busbice Some may feel direct-to-consumer (DTC) advertising may not be worth the time and money spent on it. However, a recent study shows that DTC marketing continues to be a strong driver of brand performance for selected categories and brands. |
![]() |
Leverage Science in Your Product Lifecycle By Craig Eslinger Today, frills are far less acceptable than fact. By presenting measurable scientific data during the span of a product’s lifecycle, pharma companies can prove that their product is viable, which will help lead to its success. performance for selected categories and brands. |
![]() |
Continuing Medical Education: Time for a Change By Marissa Seligman, PharmD Continuing medical education (CME) is currently going through a plethora of scrutiny and changes. Rather than perceiving the controversy surrounding CME as a tipping point toward its demise, it should be viewed as a leading indicator for positive change. |
![]() |
TRENDSETTERS: Up Close With Elaine Riddell, CEO, TNS Healthcare By Jon Brulloths In an interview with PM360, Elaine Riddell, CEO, TNS Healthcare, talks about operating models, the company’s conceptual framework, and the effect of social media. |
| IN THIS ISSUE |
| GUEST COMMENTARY HEALTHCARE HIGHLIGHTS FDA UPDATE INDUSTRY BRIEFS E-SOURCE THE MARKETING INSIDER EXECUTIVE COACH PM360 BOOK REVIEW LIFESTYLE COMMON SENSE UNDERSTANDING THE PHYSICIAN END-OF-LIFECYCLE STRATEGIES THE SCENE CALENDAR CUTTING EDGE MOVERS AND SHAKERS DESTINATIONS PHOTO FINISH |